Log in
Enquire now
OncoSenX

OncoSenX

OncoSenX is a spinout company of Oisin Biotechnologies, formed to develop programmable suicide gene therapy to kill cancerous cells.

OverviewStructured DataIssuesContributors
Is a
Organization
Organization
Company
Company
AngelList URL
angel.co/company/oncosenx
B2X
B2B
B2B
0
B2C
B2C
CEO
‌
Matthew Scholz
Company Operating Status
Active
Country
United States
United States
Crunchbase URL
crunchbase.com/organiz...oncosenx
Date Incorporated
2018
Founded Date
2021
0
Founder
‌
Matthew Scholz
Industry
Medicine
Medicine
Oncology
Oncology
Therapeutics
Therapeutics
Gene therapy
Gene therapy
Therapy
Therapy
Cancer
Cancer
Biomedical engineering
Biomedical engineering
Biopharmaceutical
Biopharmaceutical
Technology
Technology
Synthetic biology
Synthetic biology
•••
Investors
‌
Helios Capital
‌
Canadian Institutes Of Health Research , Instituts De Recherche En Santé Du Canada
Kingsley Advani
Kingsley Advani
Jim Mellon
Jim Mellon
Latest Funding Round Date
August 2021
Latest Funding Type
Seed
Seed
LinkedIn URL
@company/oncosenx
Location
Seattle
Seattle
Number of Employees (Ranges)
1 – 10
Spun Out From
Oisin Biotechnologies
Oisin Biotechnologies
Total Funding Amount (USD)
19,700,000
Official Website
oncosenx.com
Wellfound ID
oncosenx

Find more companies like OncoSenX

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.